NCT03918967View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

June 6, 2020

Study Completion Date

June 6, 2020

Conditions
Healthy
Interventions
DRUG

CT-G11

oral tablet of CT-G11 Experimental Drug

DRUG

CT-G20

oral tablet of CT-G20 Experimental Drug

DRUG

CT-G11 Placebo

oral tablet of Placebo

DRUG

CT-G20 Placebo

oral tablet of Placebo

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Celltrion
All Listed Sponsors
lead

Celltrion

INDUSTRY

NCT03918967 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants | Biotech Hunter | Biotech Hunter